EUVIMEDEUVIMED entdecken
Crossref

SARS ‐ CoV ‐2 infection after August 2022 in Dutch blood donors without serological signs of prior infection

Franke A Quee iD, B M Hogema, E Slot, K van den Hurk iD, H L Zaaijer

Vox Sanguinis · 2025

DOI: 10.1111/vox.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Franke A Quee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Donor Studies, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Blood Donors, COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Ministerie van Volksgezondheid, Welzijn en Sport, Sanquin PPOC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives After several years of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) circulation in the Netherlands, most individuals acquired the infection. However, an unknown number of uninfected persons could still be solely dependent on vaccination for protection. In this study, we aimed to retrospectively quantify the proportion of blood donors, without signs of prior SARS‐CoV‐2 infection, who acquired SARS‐CoV‐2 infection after August 2022. Materials and Methods Based on data collected in previous SARS‐CoV‐2 serosurveillance studies, we created a cohort of donors who tested negative for anti‐nucleocapsid (NC) antibodies between August 2022 and September 2023. If these donors donated blood during the follow‐up period, between 1 October 2023 and 12 September 2024, their donation was again tested for anti‐NC to see whether they seroconverted.

Results

Of the 992 donors whose donation(s) tested negative for anti‐NC between August 2022 and September 2023, 824 (83%) donated during the follow‐up period. Older donors were overrepresented in the study. Of the included donors, 67% seroconverted for anti‐NC after August 2022.

Conclusion

The majority of Dutch blood donors who were still uninfected acquired primary infection after August 2022, coinciding with the circulation of SARS‐CoV‐2 omicron variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsCOVID-19SARS-CoV-2Antibodies, ViralHumansNetherlandsMaleMiddle AgedAdultFemaleRetrospective StudiesSeroepidemiologic StudiesAgedYoung Adult

Stichwörter der Autor:innen

SARS‐CoV‐2antibodiesblood donorinfectionseroprevalenceserosurveillance

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Donor Studies, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
  • Blood-Borne Infections, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
  • Department of Virology, Sanquin Diagnostic Services, Amsterdam, the Netherlands.
  • Department of Medical Affairs, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
  • Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, the Netherlands.

ORCID-Profile: Franke A Quee, K van den Hurk

Förderung

  • Ministerie van Volksgezondheid, Welzijn en Sport
  • Sanquin PPOC

Zitieren

APA

Quee, F. A., Hogema, B. M., Slot, E., van den Hurk, K., & Zaaijer, H. L. (2025). SARS ‐ CoV ‐2 infection after August 2022 in Dutch blood donors without serological signs of prior infection. Vox Sanguinis. https://doi.org/10.1111/vox.70077

Vancouver

Quee FA, Hogema BM, Slot E, van den Hurk K, Zaaijer HL. SARS ‐ CoV ‐2 infection after August 2022 in Dutch blood donors without serological signs of prior infection. Vox Sanguinis. 2025. doi:10.1111/vox.70077

BibTeX
@article{Quee2025,
  author = {Quee, Franke A and Hogema, B M and Slot, E and van den Hurk, K and Zaaijer, H L},
  title = {SARS ‐ CoV ‐2 infection after August 2022 in Dutch blood donors without serological signs of prior infection},
  journal = {Vox Sanguinis},
  year = {2025},
  doi = {10.1111/vox.70077}
}
Kostenlos starten →